Total Capacity
180,000 L
(15,000 L x 12)
-
2025
-
JAN.
Received an overall 'Low Risk' rating from Sustainalytics
Received 'Leadership' status and an A- rating for Water Security from the CDP
-
FEB.
ADC Facility CGMP Ready
Opened Tokyo office
-
APR.
Plant 5 CGMP Ready
- PLANT
5
Construction
24 months to
CGMP ready - PLANT
-
JUN.
Launch of drug screening services, Samsung Organoids
-
-
2024
-
NOV.
ISO 37301 Certification (Compliance Management System)
-
OCT.
Launch of high-concentration formulation platform, S-HiCon™
-
SEP.
Launch of high-performing CHO-based cell line development platform, S-AfuCHO™
Launch of a precise charge variant modulation platform, S-Opticharge™
-
AUG.
Joined the Pharmaceutical Supply Chain Initiative (PSCI) as a supplier partner
-
JUN.
Launch of intensified cell culture platform, S-Tensify™
-
MAR.
Received A- rating “Honors Award” in carbon management sector by CDP awards
-
JAN.
Awarded the Platinum Sustainability Rating from EcoVadis
-
-
2023
-
NOV.
Launch of proprietary TGE platform, S-CHOsient™
-
AUG.
Launch of Customized CMC service, SelecTailor™
-
JUN.
Plant 4 CGMP ready
- PLANT
4
Total Capacity
240,000 L
(15,000 L x 12 /
10,000 L x 6)Construction
31 months to
CGMP ready - PLANT
-
APR.
Plant 5 groundbreaking
-
MAR.
Opened the New Jersey Sales Office (Samsung Biologics America)
Pfizer manufacturing partnership
-
JAN.
Received Terra Carta Seal
for commitment to sustainability
-
-
2022
-
OCT.
Plant 4 completion
ISO 37001 Certification
(Anti-bribery Management Systems)Launch of proprietary platforms,
S-DUAL™ & DEVELOPICK™ISO 27017 Certification
(Cloud Security Management System) -
AUG.
Received Frost & Sullivan’s
“Enlightened Growth Leadership” Award -
APR.
Full acquisition of Samsung Bioepis
-
-
2021
-
DEC.
ISO 9001 Certification
(Quality Management System) -
MAY.
ISO Certifications:
14001 (Environmental Management System)
22301 (Business Continuity Management System)
45001 (Health & Safety Management System)
50001 (Energy Management System)Signed a contract for the complete production of Moderna COVID-19 vaccine
-
APR.
10th Anniversary
-
-
2020
-
NOV.
Plant 4 groundbreaking
-
OCT.
Opened the San Francisco R&D Center
-
AUG.
Launch of proprietary cell line development platform,
S-CHOice® -
MAY.
ISO 22301 Certification for Plant 3
(Business Continuity Management System) -
APR.
Formed a manufacturing partnership with Vir for its COVID-19 treatment
-
-
2019
-
NOV.
ISO 27001 Certification
(Information Security Management System)
-
-
2018
-
OCT.
Received the authorized economic operator (AEO) certification
Plant 3 CGMP Ready
- PLANT
3
Total Capacity
180,000 L
(15,000 L x 12)Construction
34 months to
CGMP ready - PLANT
-
APR.
First domestic pharmaceutical company to receive ISO 22301 certification
(Business Continuity Management System)
-
-
2017
-
DEC.
First Approval of Plant 2 by EMA
-
SEP.
First Approval of Plant 2 by FDA
-
MAY.
First Approval of Plant 1 by PMDA
-
-
2016
-
NOV.
IPO on KOSPI
-
JUL.
First Approval of Plant 1 by EMA
-
FEB.
Plant 2 DS CGMP Ready
- PLANT
2
Total Capacity
180,000L
(15,000 L x 10/
1,000 L x 4)Construction
29 months to
CGMP ready - PLANT
-
-
2015
-
DEC.
Plant 3 groundbreaking
-
NOV.
First approval of Plant 1 by FDA
-
-
2014
-
APR.
DP manufacturing Partnership with BMS
-
-
2013
-
SEP.
Plant 2 groundbreaking
-
AUG.
Plant 1 DP CGMP ready
-
JUN.
Plant 1 DS CGMP ready
- PLANT
1
Total Capacity
30,000 L
(5,000 L x 6)Construction
25 months to
CGMP ready - PLANT
-
-
2012
-
JUL.
Plant 1 mechanical completion
-
-
2011
-
MAY.
Plant 1 groundbreaking
-
APR.
Foundation of Samsung Biologics
-